Q1 results on July 28, 2016

| Updated on December 13, 2017 Published on July 01, 2016

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 28, 2016, inter alia, to consider and approve Un-Audited Financial Results for the first quarter ended June 30, 2016 (Q1).

Source : BSE - >

Published on July 01, 2016
This article is closed for comments.
Please Email the Editor